Leap Therapeutics
LPTX
LPTX
46 hedge funds and large institutions have $43M invested in Leap Therapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
46
Holding in Top 10
–
Calls
$974K
Puts
–
Top Buyers
| 1 | +$737K | |
| 2 | +$528K | |
| 3 | +$387K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$363K |
| 5 |
Two Sigma Advisers
New York
|
+$152K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$1.8M | |
| 3 | -$568K | |
| 4 |
6CM
683 Capital Management
New York
|
-$452K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$295K |